MCM
SUPN icon

Matarin Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Matarin Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.26M Sell
129,607
-59,271
-31% -$1.28M 0.8% 43
2020
Q3 		$3.94M Sell
188,878
-27,865
-13% -$632K 0.83% 41
2020
Q2 		$5.15M Sell
216,743
-171,242
-44% -$3.78M 1.03% 17
2020
Q1 		$6.98M Sell
387,985
-21,923
-5% -$461K 1.08% 11
2019
Q4 		$9.72M Sell
409,908
-13,322
-3% -$324K 0.93% 21
2019
Q3 		$11.6M Buy
423,230
+305,082
+258% +$9.04M 0.88% 36
2019
Q2 		$3.91M Buy
+118,148
New +$4.05M 0.28% 133

Other funds holding SUPN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return